Continuing medical education courses online from American Gastroenterological Association - AGA. Neuroendocrine Tumors: Timely Diagnosis and Optimal Intervention - Earn free cme credits at the CME Cafe with multimedia - continuing medical education for doctors, nurses and other medical professionals.

	•	NSAID-Induced GI Toxicity
	•	Updates in the Management of Chronic Constipation
	•	Effective Management of Ulcerative Colitis

Effective Management of Ulcerative Colitis
Launch Program

Program Overview
	Ulcerative colitis (UC) is a treatable condition that affects more than 500,000 Americans. Most UC cases are mild to moderate and can be managed medically. Until recently, management options heavily relied on oral medications that require frequent daily doses or the application of topical agents, which many patients find inconvenient. The availability of newer formulations and development of new delivery technology might improve management of UC. During this program, three renowned experts discuss the effective management of ulcerative colitis using a case-based approach to explore key clinical questions relating to disease management.

Audience
	Clinical gastroenterologists in academia and community practice, gastroenterology trainees, as well as other GI healthcare providers

Learning Objectives
	This AGA CME Café, focused on the effective management of the patient with ulcerative colitis, will meet the following objectives: Review the most current, comprehensive information on managing ulcerative colitis and Crohn's disease. Educate clinical gastroenterologists on recent advances in understanding the genetics and inflammatory mechanisms that underlie IBD and implications for practice. Provide clinicians the opportunity to discuss difficult patient cases with recognized authorities in the field of IBD.

Accreditation Statement
	The American Gastroenterological Association Institute (AGA Institute) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement
The AGA Institute designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty
	Jane E. Onken, MD, MHS Assistant Professor of Medicine Duke University Medical Center >> Read Biography Sunanda V. Kane MD, MSPH Associate Professor of Medicine University of Chicago Pritzker School of Medicine >> Read Biography Kim L. Isaacs, MD, PhD Professor of Medicine Division of Gastroenterology and Hepatology University of North Carolina, Chapel Hill >> Read Biography

Faculty Disclosure Information
	In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Jane E. Onken, MD, MHS Grant/Research Support: Osiris Therapeutics, Otsuka and Centocor. Consultant: Salix Sunanda V. Kane MD, MSPH Grant/Research Support: Procter and Gamble, Salix and GlaxoSmithKline Consultant: Aventis, Centocor, Elan, Ferring, Nisshin-Kyorin Pharmaceuticals, Procter and Gamble, Shire, TAP Pharmaceutical Products Inc. and UCB. Speakers Bureau: Abbott, Astra-Zeneca, Centocor, Glaxo, Novartis, Procter and Gamble, Prometheus, Salix, Solvay and TAP Pharmaceutical Products Inc. Kim L. Isaacs, MD, PhD Grant/Research Support: Abbott, Centocor, Elan and Otsuka.

Software Requirements
	Suggested Minimum Software Requirements Windows Me / XP / 2000. 800 MHz P3 processor. 256 MB RAM. Microsoft Internet Explorer (6.0 or higher). 16-bit sound card and Windows Media Player (9.0 or greater). Video Card capable of 16-bit color. Adobe Acrobat 6.0 or greater.

Release Date
	May 2006

Expiration Date
	May 2008

Fee
	Free-of-charge

Sponsorship and Support
	Sponsored by the AGA Institute. Supported through an educational grant from Shire Pharmaceuticals.

- - - - -